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Abstract
Introduction
Few studies described strategies to improve the use of diagnostic tests in intensive care
units (ICU). No study assessed whether their impact was sustained or not. In this study, we
assessed whether a multi-faceted intervention for more appropriate use of laboratory testing
can decrease the number of tests, is sustainable, is not associated with additional morbidity
and represents a potential cost saving.
Material and methods
An open-label prospective cohort study in two separated units of the same medical intensive
care unit (ICU) including respectively 3315 and 2392 consecutive patients. After the obser-
vation period (2010), a reduction in ICU A of unnecessary diagnostics tests as part of a pro-
gram including senior supervisory of juniors’ orders, encouragements for orders
containment at each everyday round discussions (period 2; 2011). Period 3 (2012) con-
sisted in the prolongation of the protocol as a routine care without supervision; Period 4
(2013) was a new period of observation without intervention. No modification was imple-
mented in ICU B in periods 2–4.
Results
After the intervention, a decrease in the overall number of tests per ICU-patient-days (37.3
±5.5 (baseline) to 15.2±3.2 (- 59%); p<0.0001) was observed. The total cost of the tests
decreased from 239±41 to 104±28 euros per ICU-patient days; p<0.0001. The effect on lab-
oratory test orders was sustainable in period 3 (-49%) and 4 (-30%). No significant second-
ary effect of the intervention was observed in period 2. In ICU B, there was no significant
change in the overall laboratory test orders in between the periods.
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Conclusions
Laboratory test containment is effective, likely safe and sustainable provided that an educa-
tional program is repeatedly promoted, that it makes sense for the whole team, that senior
and junior physicians are both committed in the program, and that encouragements for labo-
ratory orders containment at each everyday round discussions.
Introduction
Improving patient health care is a priority. This can be done by improving quality and not nec-
essarily quantity. A large proportion of hospital spending is constituted by laboratory and
radiological tests [1]. These tests are generally overused in hospitals [2–3]. Because of both
budget deficits and increase of health care expenditures [4–5], efforts are welcome to reduce
unnecessary medical costs while providing high-quality health care. It has been estimated that
30% of computed tomography [6] or up to 20% laboratory tests may be unnecessary [7].
Decreasing the demands of unnecessary tests should be an everyday life task especially when
they do not impact the care of patients.
The intensive care units (ICUs) do not escape this phenomenon. Most patients are moni-
tored with several laboratory tests each day. Chemistry and haematology tests constitute 10%
of total costs [1]. This could be explained by the severity of disease, the ease of blood drawing
from indwelling catheters, the difficulty of implementing sustainable changes in a multidisci-
plinary environment and the absence of guidelines defining which frequency of routine labo-
ratory tests is adequate [8–10]. Excessive use of laboratory blood tests increases resource
utilization. It also contributes to blood loss and patient’s discomfort, and may eventually lead
to improper diagnosis and treatment [1,11–13].
Few studies have described strategies to improve the use of diagnostic tests [14–17]. Most
of them described the short term economic impact of a protocol. To our knowledge, no study
assessed whether this short term impact was sustained or not.
Beyond the economic issue, the educational aspect of the appropriate use of laboratory tests
is crucial. In line with this educational perspective, we developed a new multi-faceted interven-
tion for more appropriate use of laboratory testing in our medical ICU with the goal of limiting
orders to only those necessary laboratory tests. We hypothesized that the introduction of new
guidelines for ordering laboratory tests in an ICU could significantly decrease the number of
tests in a safe and sustainable way.
Material and methods
Setting
The study was carried out in two 12-bed ICUs (ICU A and ICU B) of the same medical depart-
ment in a University teaching Hospital. Both ICUs have the same case mix but function as
independent units without any mutual medical staff. The protocol was willingly only intro-
duced and supervised in ICU A, ICU B serving as control. Three residents, one junior physi-
cian and three senior physicians worked in each ICU without difference in senior physicians’
age, gender and years of ICU practice. The residents left the ICU every 6 months. The junior
physician moved from one unit to the other every one year. In ICU A, the educational pro-
gram relied on two senior physicians (CB and BA) and two residents (CM and SMA, each a
semester).
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Patients
All consecutive patients between January 1, 2010 and December 31, 2012, then from June 1,
2013 to December 31, 2013 were enrolled in the study. Demographic information included
age, patient’s severity of illness score (SAPS II) and ventilation requirement [18].
Periods of the study (Fig 1)
Period 1 (2010). For both ICUs, a first observation period was defined to determine the base-
line number of laboratory tests which were ordered by the medical staff (mainly residents but
also senior physicians). The total number of each laboratory tests was retrospectively calculated
by administrators.
Period 2 (2011). The ICU A team decided to implement the intervention. Reduction of
unnecessary diagnostics tests was part of an educational program including several points
which were written in a prescribing guide (Fig 1). Our new policy included encouragements to
reduce orders rather than penalty in case of over prescription since we were concerned that
too much strictness may actually lead to more adverse events.
The medical staff of the ICU B was aware of this program and could feel free to implement
it. This second unit was considered as the “control unit”, even if they could also apply the pro-
tocol. No medical staff was shared between units A and B during this year.
Period 3 (2012). This period consisted in prolonging the protocol as part of routine care
without supervision, educational sessions or feedback. However, educational key messages on
laboratory test orders merged into the entire junior physicians’ educational package. Labora-
tory orders were not challenged during the daily visits by senior physicians. The written guide
was not available.
Fig 1. Characteristics of interventions according to different periods.
https://doi.org/10.1371/journal.pone.0214802.g001
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Period 4 (last 7 months of 2013). After a washout period of 4 months, this period was
defined as the “reality period” i.e. a new period of observation without intervention as was
done in the initial period 1. ICU B served as the control without any interventions or imple-
mentations in periods 2–4.
During period 3 and 4, the staff was not aware of any prolongation of the observational
assessment of test orders. This was decided to remain as close as possible from the routine of
the ICUs.
Measurements
Financial administrators (GN, LC) of the Laboratory Department provided us with all monthly
data concerning ICU orders (no individual data was provided). From the central database,
they extracted the number of patients, number of laboratory tests and their respective costs.
For each unit (A or B), within each period (from period 1 to period 4), the reported results
include the number of patients included, the number of patient-days (sum of patients X the
mean length of ICU stay of the unit in which the patient has been admitted), the global number
of tests ordered in each unit, the number of tests ordered per patient (sum of the tests / sum of
patients), the number of tests per ICU-patient days (sum of the tests / sum of the patient-days).
Biochemical tests include all tests described in Table 1.
Haematological tests include coagulation tests and blood count. Immunological tests
mainly include a battery of antibodies, complement, Coomb’s test, T cell subpopulations.
Pharmacological tests are limited to serum drug dosage. The cost of biological tests and their
evolution during the study periods are presented in Table 2.
End points
The primary end point is the reduction in the number of laboratory tests ordered in period 2
vs. 1
Secondary endpoints include the consecutive decrease in costs associated with test orders,
the comparison of number of tests in ICU A within all periods. Providing that ICU B was the
control unit for the baseline period, the number of tests in ICU A was compared with ICU B
within all subsequent periods. Also, potential secondary effects of the reduction in the moni-
toring of laboratory tests were prospectively assessed during the intervention phase (twice a
day at morning and afternoon round) and registered by the whole team (junior and senior
physicians) in period 2 and only by senior physicians thereafter.
They were defined by clinically significant consequences of metabolic disorders (cardiac
arrhythmia or change in electrocardiographic registration prompting an urgent correction of
potassium or calcium, convulsive states related to calcium or sodium disorders).
Ethics statement
The study was approved by ethics committee of the Société de Réanimation de Langue Fran-
çaise (n˚CE SRLF 13–18).
Statistical analysis
Ordinal and continuous variables with a normal distribution are expressed as mean ± SD.
One-way analysis of variances (ANOVA) or Kruskall-Wallis when appropriate, were per-
formed to study the significance between groups over different periods. The p values were
two-sided, and the level of significance was set at< 0.05. Given the very high number of
patients, which gives the study the power to identify very small and not clinically relevant
An educational approach to improve the appropriateness of laboratory test orders in the ICU
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differences between periods, we willingly decided not to report p value for clinical characteris-
tics presented in Tables 3 and 4 (e.g. 1 point of SAPS II does not reflect any real clinical differ-
ence between two patients).
Results
During the study, a total of 3315 patients were admitted to ICU A and 2392 in ICU B.
Period 1
The orders of all laboratory tests are summarized in Table 1. Biochemical tests accounted for
the vast majority of the overall orders (86–88%). At baseline, despite not similar, the number
of laboratory tests was close between the two medical ICUs, with a difference of no more than
10–20 tests/patient.
Endpoints
No clinically relevant difference in age, SAPS II and number of mechanically ventilated
patients was observed in ICU A within different periods (Table 3).
Primary endpoint (Tables 4 and 5 and Fig 2). After the intervention (period 2), the over-
all number of laboratory test per ICU-patient days decreased in ICU A from 37.3±5.5 (base-
line) to 15.2±3.2 (- 59.2%) p<0.0001 (Table 4), leading to a cost reduction (239±41 baseline vs
104±28 period 2 (euros per ICU-patient days) p<0.0001) (Table 5).
Table 1. Routine demand of main biochemical laboratory tests according to different periods.
Laboratory tests1 Period 12
2010
Period 2
2011
Period 3
2012
Period 4
2013
Creatinin 1,3 0,77 0,84 1,1
BUN 1,34 0,81 1,02 1,1
Potassium 1,35 1,08 1,43 1,42
Calcium 1,34 0,28 0,40 0,43
Glucose 1,34 0,22 0,24 0,40
Total Bilirubin 0,75 0,27 0,39 0,69
Sodium 1,35 0,97 1,16 1,29
Protide 1,35 0,23 0,29 0,43
Phosphore 1,34 0,28 0,19 0,43
CRP 0,10 0,03 0,02 0,02
BNP 0,20 0,02 0,02 0,02
PCT 0,65 0,10 0,06 0,07
Transaminases 0,56 0,22 0,3 0,46
GGT 0,43 0,18 0,3 0,46
Troponin 0,47 0,16 0,31 0,43
Blood count 1 0.74 0.89 1.12
Coagulation factors 0.41 0.28 0.29 0.38
Fibrinogen 0.33 0.35 0.40 0.53
1 Results are expressed as the overall number of test per ICU-patient days (where the ICU-patient days represent the sum of all days of all patients hospitalized in the
ICU during the period).
2 All the tests comparing period 2,3 or 4 with period 1 were significant with p value <0.0001 except Total bilirubin and Troponin (period 4 vs. period 1;p = 0.6), CRP
(period 4 vs. period 3;p = 0.06), and Firbinogen (period 3 vs. period 1;p = 0;7).
BUN blood urea nitrogen; CRP C reactive protein; BNP Brain natriuretic peptide; PCT Procalcitonin; GGT Gammaglutamyl transpeptidase
https://doi.org/10.1371/journal.pone.0214802.t001
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Other endpoints. Comparison within periods into ICU A. A decrease in the overall num-
ber of tests per patients [176 at baseline vs 76 in period 2 (- 57%)] was observed. The reduction
was more pronounced regarding biochemical tests (-60%), which accounted for 88% of the total
laboratory orders at baseline vs. 80% in period 2. The total cost of the tests decreased from
1.005.805 euros to 503.551 euros (-50%). The ratio of the overall number of tests per patient-
ICU days increased by 27% in period 3 vs. period 2 but remained lower than baseline (- 48%).
This relapse was accompanied by a total increase in cost of 39% between period 2 and 3.
Two years after baseline, during period 4, the daily demands of laboratories tests increased
in comparison with period 3 (+35%), even if they still remained lower than baseline (-30%).
Table 2. Cost£ of biological tests.
Period 1 2010 Period 2 2011 Period 3 2012 Period 4 2013
euros US dollars euros US dollars euros US dollars euros US dollars
Creatinin 2.16 2.44 1.89 2.14 1.89 2.14 1.89 2.14
BUN 2.16 2.44 1.89 2.14 1.89 2.14 1.89 2.14
Potassium 2.16 2.44 1.89 2.14 1.89 2.14 1.89 2.14
Calcium 2.16 2.44 1.89 2.14 1.89 2.14 1.89 2.14
Glucose 1.35 1.53 1.35 1.53 1.35 1.53 1.35 1.53
Total Bilirubin 3.24 3.66 2.7 3.05 2.7 3.05 2.7 3.05
Sodium 1.89 2.14 1.89 2.14 1.89 2.14 1.89 2.14
Protide 2.16 2.44 1.89 2.14 1.89 2.14 1.89 2.14
CRP 5.67 6.41 5.4 6.1 4.05 4.58 3.24 3.66
BNP 22.95 25.93 22.95 25.93 22.95 25.93 22.95 25.93
PCT 27 30.51 24.3 27.46 21.6 24.41 21.6 24.41
Transaminases 5.4 6.1 4.05 4.58 3.78 4.27 2.97 3.36
GGT 2.7 3.05 2.16 2.44 1.89 2.14 1.89 2.14
Gazometry 22.95 25.93 21.6 24.41 20.25 22.88 20.25 22.88
Troponin 17.55 19.83 17.55 19.83 17.55 19.83 17.55 19.83
Blood count 9.18 10.37 8.64 9.76 8.37 9.46 8.37 9.46
Coagulation factors 6.75 7.63 6.75 7.63 6.75 7.63 6.75 7.63
Fibrinogen 5.4 6.1 5.4 6.1 5.4 6.1 5.4 6.1
£ Current exchange rate: 1 Euro = 1.13 US Dollars
https://doi.org/10.1371/journal.pone.0214802.t002
Table 3. Demographic characteristics according to different periods.
Laboratory tests Baseline
Period 1
2010
Protocol
Period 2
2011
Routine
Period 3
2012
Reality
Period 4
20131
N patients 875 883 983 574
ICU-patient days 4138 4433 4680 2327
Age 59.0 ± 3.2 59.5 ± 2.3 58.9 ± 3.2� 58.2 ± 0.7
Rate of mechanical ventilation 64.9 ± 7.4 63.5 ± 9.1 58.0 ± 10.8 64.5 ± 7.1��
SAPS II 52.6 ± 2.8 53.2 ± 3.2 53.7 ± 4.8 50.8 ± 1.3
Mortality rate £ 22 20 21.5 19
1 Last seven months; All the tests comparing pairs of period were significant with p <0.001 except:
�p = 0.41 period 3 vs 1
��p = 0.39 period 4 vs 1 and p = 0.04 period 4 vs 2
£ no statistical difference between periods (p = 0.47)
https://doi.org/10.1371/journal.pone.0214802.t003
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No significant adverse event of the intervention was observed in 2011. No difference in
rates of mortality, transfer of patients from our ICU to cardiac intensive care unit (a marker
for delay in myocardial infarction diagnosis) was observed in period 2 vs. 1.
Comparison between ICU A and B (Table 6 and Fig 2). In ICU B, there was no real impact
of the protocol implemented in ICU A despite the proximity of both units. Considering the
entire study period, the overall laboratory test orders decreased slowly from 31.9 to 27.5 tests
per ICU-patient days.
Discussion
Identifying unnecessary tests can be a complex and challenging task since some tests remain
essential for screening, diagnosis, and monitoring of critical diseases. It is complex first
Table 4. Number and type of laboratory tests ordered in ICU A according to different periods.
Laboratory tests Baseline
Period 1
2010
Protocol
Period 2
2011
Routine
Period 3
2012
Reality
Period 4
20131
Biochemical tests
N tests 135 120 53 463 74 692 47 271
N/N patients 154.4±29.8 60.5±14.2 76.0±7.8 82.4±12.7
N/ICU-patient days 32.7±5.9 12.1±3.4 16.0±10.7 20.3±3.1
Haematological tests
N tests 15 185 10 608 12 843 10 348
N/N patients 17.4±4.2 12.0±2.1 13.1±1.8 18.0±3.1
N/ICU-patient days 3.7±0.8 2.4±0.4 2.7±2.0 4.4±0.9
Pharmacological tests
N tests 1560 1265 1569 920
N/N patients 1.8±0.5 1.4±0.3 1.6±0.4 1.6±0.3�
N/ICU-patient days 0.4±0.1 0.3±0.1 0.3±0.3 0.4±0.1
Immunological tests
N tests 517 655 530 552
N/N patients 0.6±0.5 0.7±0.4 0.5±0.3 1.0±0.5
N/ICU-patient days 0.1±0.1 0.1±0.1 0.1±0.1 0.2±0.1
Virological tests
N tests 1786 1194 1477 1304
N/N patients 2.0±0.8 1.4±0.5 1.5±0.4 2.3±0.9
N/ICU-patient days 0.4±0.2 0.3±0.1 0.3±0.2 0.6±0.2
Mycoparasitological tests
N tests 66 67 95 421
N/N patients 0.1±0.1��� 0.1±0.0�� 0.1±0.1���� 0.7±0.5
N/ICU-patient days 0.0±0.0 0.0±0.0�� 0.0±0.0 0.2±0.1
Overall number of tests per ICU-patient days 37.3±5.5 15.2±3.2 19.3±13.2 26.0±4.1
Total Euros per ICU-patient days 2 238.9 ±40.6 103.9 ±27.9 145.2±99.6 181.9 ±28.8
1 Last seven months
2 The cost does not include immunological and mycoparasitological tests
All the comparisons yielded significant differences with p<0.001 except
�no statistically significant difference between P4 and P3
�� no statistically significant difference between P1 and P2
��� no statistically significant difference between P1 and P3
���� no statistically significant difference between P2 and P3
N number of test orders; ICU Intensive care unit; SAPS Simplified acute physiology score
https://doi.org/10.1371/journal.pone.0214802.t004
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because ICU patients are critically ill and second because of the different level of experience
among physicians. This could explain a large number of tests not directly contributing to the
process of care decision. We have shown that the introduction of few simple procedures in a
medical ICU led to a significant and sustained reduction in unnecessary diagnostic and moni-
toring tests. Thereby, we achieved a major cost reduction. Whether this reduction could result
from demographic or case-mix difference between periods is not sustained by our data despite
statistically significant differences. Given the very high number of patients included in the
study, even minuscule difference between periods could indeed result in statistical difference
(e.g. 1 point of SAPS II does not reflect any real clinical difference between the patients of two
different periods). In contrast, the global cost reduction could be partly explained by the evolu-
tion of costs year after year.
We decided to unbundle the classic panel tests, such as the “ionogram”. A special attention
for each classic electrolyte (inexpensive when taken aside) should be relevant for the overall
cost reduction. Larsson et al. calculated that 5% of total costs in clinical chemistry in Sweden
could be saved based on seven of the most frequently used tests [19]. In our study, there was a
decrease in the number of orders in all the components of the laboratory, even if the results
were more pronounced in the biochemistry subunit.
Several interventions to improve physicians testing practices have been previously
described [19–21]. One recent study showed a 28% reduction in test orders in the intervention
vs. pre-intervention period which persisted one year after the intervention [22] but no previ-
ous report estimated the mid-term sustainability of this approach. The sustainability of the
intervention effect was partly lost in period 4 vs period 2,3. Even if the difference remained
Table 5. Comparison of laboratory tests costs in ICU A according to different periods.
Euros£ per ICU-patient days
Laboratory tests Period 1, 2010 Period 2, 2011 Period 3, 2012 Period 4, 2013 p�
Biochemical 182.6 ±35.5 64.9 ±26.9 96.2 ±61.5 113.5 ±16.0 <0.0001
Haematological 27.0 ± 6.2 18.1 ± 2.8 23.8 ±19.3 32.5 ± 6.2 <0.0001
Pharmacological 8.3 ± 2.5 5.6 ± 1.1 7.1 ± 6.7 8.3 ± 1.6 <0.0001
Virological 20.9 ± 7.2 15.3 ± 7.9 18.1 ±13.1 27.6 ±10.4 <0.0001
Total 238.9 ±40.6 103.9 ±27.9 145.2 ±99.6 181.9 ±28.8 <0.0001
£ Current exchange rate: 1 Euro = 1.13 US Dollars
� Kruskall Wallis test: the p value refers to the comparison test of the costs during any period vs. any other periods
https://doi.org/10.1371/journal.pone.0214802.t005
Fig 2. Comparison of the number of test per ICU-patient days between ICU A and B.
https://doi.org/10.1371/journal.pone.0214802.g002
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relevant (- 30% in overall number of tests per ICU-patient days), it is highly plausible that a
reasonable objective of test ordering in our ICU should be set between 33.2 and 14.6 tests per
ICU patient days. One could believe that the observed lost in sustainability over time could
increase. However, the main driving force of sustainability is the change in cultural paradigm
represented by the following issues.
• Who? It is likely much more challenging to implement changes, especially to observe sus-
tainability over time, with more providers coming-and-going as well as greater variations in
practice patterns. Therefore, particularly if many providers are involved, it is important to
identify in the staff a single physician committed in test orders at the bedside, ensuing the
prototype of pharmacist-assisted antibiotic prescriptions. This may be junior physicians’ role
since they have a nonstop bedside activity.
Table 6. Comparison of laboratory test orders between ICU A and B according to different periods1.
Laboratory tests Period 1 Period 2 Period 3 Period 4
ICU A ICU B ICU A ICU B ICU A ICU B ICU A ICU B
N patients 875 675 883 634 983 658 574 425
N ICU patients days 4138 3972 4433 4139 4680 4274 2327 2440
Biochemical tests
N tests 135 120 109464 53 463 104 737 74 692 101 620 47 271 53838
N/N patients 154.4 162.2 60.5 165.2 76.0 154.4 82.4 126.7
N/N ICU-patient days 32.7 27.6 12.1 25.3 16.0 23.7 20.3 22.1
Haematological tests
N tests 15 185 13 789 10 608 14 194 12 843 13 725 10 348 10291
N/N patients 17.4 20.4 12.0 22.4 13.1 20.9 18.0 24.2
N/N ICU-patient days 3.7 3.5 2.4 3.4 2.7 3.2 4.4 4.2
Pharmacological tests
N tests 1560 1629 1265 1505 1569 1677 920 883
N/N patients 1.8 2.4 1.4 2.4 1.6 2.5 1.6 2.1
N/N ICU-patient days 0.4 0.4 0.3 0.4 0.3 0.4 0.4 0.4
Immunological tests
N tests 517 282 655 613 530 460 552� 539�
N/N patients 0.6 0.4 0.7 1.0 0.5 0.7 1.0 1.3
N/N ICU-patient days 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2
Virological tests
N tests 1786 1463 1194 1588 1477 1282 1304 1129
N/N patients 2.0 2.2 1.4 2.5 1.5 1.9 2.3 2.7
N/N ICU-patient days 0.4 0.4 0.3 0.4 0.3 0.3 0.6 0.5
N Mycological tests
N tests 66 57 67 90 95 72 421 278
N/N patients 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.7
N/N ICU-patient days 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1
Overall tests
per patient
176.3 187.7 76.1 183.6 92.8 180.5 106 157.7
Overall tests per ICU-patient days 37.3 31.9 15.2 29.5 19.3 27.7 26.0 27.5
Total Euros per ICU-patient days 239 218 104 206 145 184 182 193
1 All statistical tests have been used to compare ICU A vs ICU B within each period: they were all statistically significant with p<0.0001, except
�p = 0.0526
ICU Intensive care unit
https://doi.org/10.1371/journal.pone.0214802.t006
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• With the support of whom? Junior physician should be supported by older physicians with
experience and academic teaching leadership. Even if senior physicians have been associated
with a lower guideline compliance, their expertise may supplant the age factor to contribute
to the real change we observed [23].
• When? Laboratory test orders should be discussed during the day shift at a specific time, i.e.
at the morning and afternoon round, which precludes night providers to interfere with these
orders.
• Why? To decrease laboratory test orders must make sense. If physicians (especially in youn-
ger ones [24]) generally pay more attention to expensive tests than to frequent and cheap
tests, a previous study reported no impact on the amount of laboratory orders when physi-
cians were informed of their cost [25]. We therefore did not focus our new approach on the
financial aspect, but rather on moral values that make sense to physicians.
• How? Quarterly reported feedback to nursing and medical staff was performed but was not
the key to sustainable change, instead of the content of educational sessions which is crucial.
We insisted on the association between excessive use of laboratory blood tests and inappro-
priate resource utilization, patient’s discomfort, blood loss and improper diagnosis and treat-
ment, as well as useless costs. Interestingly, a trade-off between an ambitious aim (period 2),
i.e. achievable but not sustainable and a status quo is probably a factor of sustainability
(-20% decrease as obtained in period 4 would be both achievable and sustainable).
We suspect that unnecessary tests were generally ordered by juniors residents in period 1. It
is likely that residents want to apply freshly learned theoretical knowledge without distinguish-
ing useful from futile tests [24]. Before period 2, the junior physician whose one role is to
check for test orders could have been influenced by recently graduated residents. The educa-
tional aspect of the above-cited systematic questions questions “Do I really need it? etc.” is not
sufficiently taught in books and academic lectures. In period 2, no such influence could occur
since residents have to answer to a panel of questions.
Physicians of ICU B of the same department modified their behaviour regarding laboratory
test ordering while just aware of the protocol implemented in the ICU next door. By their
move from one unit to another every one year, junior physicians might have driven this
spread.
Our study has some limitations. It only reflects the experience of a single center, and gener-
alizability may be limited as a result of differences in case mix and hospital organization, par-
ticularly in units in which many providers are involved. Second, no data were collected about
the potential savings in blood products. Third, we did not measure the feelings and confidence
of physicians. Lastly, despite no increase in mortality rate occurred and despite complications
due to a missed test were not observed, we cannot exclude that orders reduction could result
in an unidentified delayed adverse effects such as delay in the diagnosis of myocardial infarc-
tion or acute kidney injury. However, concerning troponin dosage, no study has shown the
clinical benefit of a systematic daily order. Had a clinically significant myocardial ischemia
occurred, we could have diagnosed it via cardiac arrhythmias or fatal events, all outcomes care-
fully recorded during the study. Moreover, should a clinically relevant delay in myocardial
infarction diagnosis and management have occurred, a higher proportion of patients undergo-
ing percutaneous coronary intervention or surgical procedure could have been observed. This
was not the case. Concerning acute kidney injury, blood urea and creatinin were ordered once
a day except in special indications (such as a decision to initiate renal replacement therapy in
which a second dosage the same day could be useful), which makes delay in recognizing renal
dysfunction less likely.
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Conclusion
A policy of laboratory test orders containment could be effective, likely safe and sustainable,
provided that the following points are organized. An educational program for test contain-
ment must make sense to everybody involved in the patient’s care. Senior and junior physi-
cians must be both committed in the program. Encouragements and discussions for
laboratory test orders containment must be included in the everyday round discussions.
Despite no specifically reported data, we believe there was no increase in harm or diagnostic
delays associated with this policy.
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